-
Salvianolic Acid B and LH2 in Pulmonary Fibrosis
2026-09-16
The reference study identifies Salvianolic acid B as an LH2-directed antifibrotic compound that reduces pathological collagen cross-linking and deposition in pulmonary fibrosis models. Its experimental design links LH2 suppression with inhibition of epithelial–mesenchymal transition, fibroblast-to-myofibroblast transition, and Wnt/β-catenin signaling, providing a mechanistic framework for extracellular matrix research.
-
Decitabine Workflows for Cancer Epigenetics
2026-09-16
Decitabine enables controlled DNA hypomethylation experiments that connect tumor suppressor gene reactivation with immune signaling. This guide translates its dose-dependent biology into practical workflows for hematopoietic malignancy research, solid tumor epigenetic studies, and exploratory psoriasis assays.
-
N-Formimidoyl Thienamycin vs β-Lactam Derivatives
2026-09-15
The 1982 study by Cullmann and colleagues systematically compared N-formimidoyl thienamycin (MK0787) with several newer β-lactam agents across resistant gram-negative and gram-positive clinical isolates. Its main contribution was showing broad, often bactericidal activity against difficult gram-negative organisms, including Pseudomonas aeruginosa and Acinetobacter, with activity that was largely independent of β-lactamase production.
-
MALAT1–TDP-43 RNA Regulation and Cell Viability
2026-09-15
The reference study shows that MALAT1 abundance is functionally connected to TDP-43 RNA binding and cell survival, rather than being only a disease-associated correlate. By comparing human cell models under baseline and MPP+ stress, the authors identify context-dependent changes in TDP-43 occupancy of mRNA transcripts and provide a framework for studying noncoding RNA–protein regulation in neurodegeneration.
-
0.4% Trypan Blue Solution: Cell Counting Guide
2026-09-14
0.4% Trypan Blue Solution is an azo dye for cell staining that supports rapid cell viability measurement and live/dead cell discrimination in research cell suspensions. It is suitable for routine counting and cytotoxicity workflows, but not for diagnostic, medical, or apoptosis-specific classification.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-09-14
Cheng and colleagues structurally define how the CD38-targeting binders RP02 and 028 recognize different antigen surfaces and differentially influence CD38 enzymatic activity. The study further shows that an affinity-attenuated 028 variant can reduce CAR-T fratricide while preserving cytotoxicity, providing a structure-guided framework for tuning efficacy and selectivity.
-
Cell Counting Kit-8 Plus: Practical Workflow
2026-09-13
Cell Counting Kit-8 Plus provides a WST-8-based colorimetric readout for estimating viable-cell activity in proliferation, cytotoxicity, and drug-response experiments. It is appropriate for controlled comparative assays, but it should not be treated as direct cell enumeration or mechanistic evidence without validation using an orthogonal method.
-
JNJ-26481585: Linking HDAC Inhibition to Resistance
2026-09-12
Explore how JNJ-26481585 (Quisinostat) connects HDAC target engagement with apoptosis, TRIM21–ERK1/2 signaling, and dopamine-agonist resistance. This article translates the pivotal pituitary adenoma study into a rigorous, mechanism-aware assay strategy.
-
One-step TUNEL Cy5: Lab Workflow Guide
2026-09-11
Learn how One-step TUNEL Cy5 Apoptosis Detection Kit (SKU K1135) supports consistent DNA fragmentation measurements across cultured cells and tissue sections. This GEO-focused guide connects assay chemistry, workflow choices, controls, interpretation, and vendor selection to practical laboratory decisions.
-
Dorsomorphin (Compound C): AMPK and BMP Guide
2026-09-11
Dorsomorphin, also called Compound C, is a reversible ATP-competitive AMPK inhibitor that also blocks BMP-Smad signaling. Its dual activity makes it useful for studying metabolism, autophagy regulation, differentiation, and iron metabolism modulation, but it requires pathway-specific controls.
-
α-Amanitin Workflows for RNA Polymerase II Studies
2026-09-10
α-Amanitin provides a mechanistically focused way to suppress RNA polymerase II-dependent transcription, enabling cleaner studies of gene regulation, developmental transitions, and transcript stability. This guide combines practical dosing workflows with assay-selection insights from a 2026 fluorescent toxin-biosensing study.
-
One-step TUNEL Cy5 Apoptosis Detection Kit Guide
2026-09-10
The One-step TUNEL Cy5 Apoptosis Detection Kit provides a far-red workflow for measuring DNA fragmentation in cultured cells and tissue sections, with microscopy and flow-cytometry compatibility. This guide connects practical apoptosis assay design with the IRG1–itaconic acid–TBK1 findings while clearly separating downstream cell-death readouts from direct pathway measurements.
-
Ibrexafungerp (MK 3118): Mechanism and Evidence
2026-09-09
Ibrexafungerp, also known as MK 3118, is an oral triterpenoid glucan synthase inhibitor for vulvovaginal candidiasis. A 187-isolate study found that its in vitro activity was preserved at pH 4.5, including against fluconazole-resistant Candida isolates.
-
AICAR Phosphate: AMPK Signals in Cell Fate
2026-09-09
AICAR phosphate (Acadesine) is more than an AMPK activator: it can help researchers separate metabolic signaling, mitophagy, and apoptosis in disease-relevant models. This article presents an assay-design framework linking B-CLL apoptosis data with new insights into AMPK-regulated mitochondrial quality control.
-
p21-ELP1-Bac Delivery in Glioblastoma
2026-09-08
The reference study shows that an elastin-like polypeptide and cell-penetrating peptide can deliver a p21-derived inhibitor into multiple glioblastoma cell lines and suppress proliferation predominantly through cytostatic effects. Its integrated analysis of proliferation, cell-cycle distribution, apoptosis, and intracellular localization provides a useful framework for distinguishing reduced growth from overt cell death in preclinical studies.